September 2019

Joe Biden’s Digital Ads Are Disappearing. Not a Good Sign, Strategists Say.

Joseph R. Biden Jr.’s presidential campaign has sharply scaled back his online advertising, cutting spending so severely since August that he is now investing only a fraction of what his top rivals are on Facebook and Google, the two dominant internet platforms. In a race where many voters are following politics on their smartphones, Mr.

Joe Biden’s Digital Ads Are Disappearing. Not a Good Sign, Strategists Say. Read More »

Tokyo Olympic organizers: 6,900 tickets bought through fraud

Tokyo Olympic organizers are investigating the fraudulent purchase of 6,900 tickets worth 180 million yen ($1.67 million) that were obtained in an online lottery for Japan residents. “We are consulting with the police on this matter, and if there are other cases where unauthorized purchases are suspected, we will deal with those as needed,” Tokyo

Tokyo Olympic organizers: 6,900 tickets bought through fraud Read More »

Asian shares lower on jitters over US policy toward China

Shares were mostly lower in Asia after talk of limits on U.S. stock listings by Chinese companies undermined optimism over progress in trade negotiations. Chinese manufacturing data was slightly better than analysts’ estimates, but Friday’s downbeat mood on Wall Street carried over into Monday’s trading. Tokyo’s Nikkei 225 index lost 0.6% to 21,755.84 and the

Asian shares lower on jitters over US policy toward China Read More »

Thai prime minister advises masks against Bangkok smog

Thailand’s prime minister has urged people in Bangkok to wear face masks to filter out unhealthy air pollution as smog enveloped the capital. Prime Minister Prayuth Chan-ocha warned in a statement on his Facebook page Monday that the concentration of tiny dust particles had reached unsafe levels and said he ordered government agencies to expedite

Thai prime minister advises masks against Bangkok smog Read More »

CVS Suspends Sale Of Popular Heartburn Drug Zantac Over Possible Cancer Link

Sept 28 (Reuters) ― CVS Health Corp said on Saturday it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products by the U.S. Food and Drug Administration. The FDA said earlier this month that

CVS Suspends Sale Of Popular Heartburn Drug Zantac Over Possible Cancer Link Read More »